 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Other > F H Faulding & Co Limited
 |
F H Faulding & Co Limited |
 |
 |
 |
PROFILE |
 |
F. H. Faulding & Co, which is being bought Mayne Nickless, the US' Alpharma, and Israel's Teva Pharmaceutical Industries in a 3-way breakup, makes pharmaceutical and and health products in Australia, China, and the US. Its Healthcare division makes and sells consumer products focused on vitamin and health supplements, skincare products and over-the-counter pharmaceuticals; it also provides community pharmacies and hospitals with distribution and management services. The Pharmaceutical division markets branded prescription pharmaceuticals and develops drug-delivery systems; it also includes the Purepac oral generic business in the US, and a generic injectable business operating in 70 countries around the globe.
COMPETITION |
 |
Bristol-Myers Squibb Company (BMY)
IVAX Corporation (IVX)
Teva Pharmaceutical Industries Limited (TEVA)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: June
2000 Sales (mil.): 2,406.10
1-Yr. Sales Growth: 15.9%
Employees: 4,300
Revenue per employee: $559,558.14
KEY PEOPLE |
 |
Edward D. Tweddell
CEO
Iain Kirkwood
CFO
CONTACT INFO |
 |
115 Sherriff St.
Underdale South Australia 5032, Australia
Phone: 61-882-6500
Fax: 61-882-5648
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |